Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/97701
Title: Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17
Author: Moreno Càceres, Joaquim
Caja Puigsubirà, Laia
Mainez Villoro, Jessica
Mayoral, R.
Martín-Sánz, P.
Moreno-Vicente, R.
Pozo, Miguel A. del
Dooley, Steven
Egea Guri, Gustavo
Fabregat Romero, Isabel
Keywords: Factor de creixement epidèrmic
Apoptosi
Fosforilació
Epidermal growth factor
Apoptosis
Phosphorylation
Issue Date: Jul-2014
Publisher: Nature Publishing Group
Abstract: Transforming growth factor-beta (TGF-β) plays a dual role in hepatocytes, inducing both pro- and anti-apoptotic responses, whose balance decides cell fate. Survival signals are mediated by the epidermal growth factor receptor (EGFR) pathway, which is activated by TGF-β in these cells. Caveolin-1 (Cav1) is a structural protein of caveolae linked to TGF-β receptors trafficking and signaling. Previous results have indicated that in hepatocytes, Cav1 is required for TGF-β-induced anti-apoptotic signals, but the molecular mechanism is not fully understood yet. In this work, we show that immortalized Cav1−/− hepatocytes were more sensitive to the pro-apoptotic effects induced by TGF-β, showing a higher activation of caspase-3, higher decrease in cell viability and prolonged increase through time of intracellular reactive oxygen species (ROS). These results were coincident with attenuation of TGF-β-induced survival signals in Cav1−/− hepatocytes, such as AKT and ERK1/2 phosphorylation and NFκ-B activation. Transactivation of the EGFR pathway by TGF-β was impaired in Cav1−/− hepatocytes, which correlated with lack of activation of TACE/ADAM17, the metalloprotease responsible for the shedding of EGFR ligands. Reconstitution of Cav1 in Cav1−/− hepatocytes rescued wild-type phenotype features, both in terms of EGFR transactivation and TACE/ADAM17 activation. TACE/ADAM17 was localized in detergent-resistant membrane (DRM) fractions in Cav1+/+ cells, which was not the case in Cav1−/− cells. Disorganization of lipid rafts after treatment with cholesterol-binding agents caused loss of TACE/ADAM17 activation after TGF-β treatment. In conclusion, in hepatocytes, Cav1 is required for TGF-β-mediated activation of the metalloprotease TACE/ADAM17 that is responsible for shedding of EGFR ligands and activation of the EGFR pathway, which counteracts the TGF-β pro-apoptotic effects. Therefore, Cav1 contributes to the pro-tumorigenic effects of TGF-β in liver cancer cells.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1038/cddis.2014.294
It is part of: Cell Death and Disease, 2014, vol. 5, p. e1326
Related resource: http://dx.doi.org/10.1038/cddis.2014.294
URI: http://hdl.handle.net/2445/97701
ISSN: 2041-4889
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)

Files in This Item:
File Description SizeFormat 
648204.pdf1.8 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons